{
  "issued_date": "2010-06-28", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON085061", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2010/054", 
    "Audience": "Healthcare professionals", 
    "Published": "28 June 2010 at 15:30", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "5", 
    "Price": "Free", 
    "ISBN/ISSN": "None", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "Appendix to MDA/2010/054 - Interpretation of FHR traces/cardiotocographs", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/con085078.pdf", 
      "filename": "downloads/8266b9617a04fd706fe0fba7f24bd6f085174c1c/con085078.pdf", 
      "original_filename": "con085078.pdf"
    }
  ], 
  "body": "## Device\n\nFetal monitor/cardiotocograph (CTG).\n\nThis replaces SN 2002(23) issued August 2002.\n\nCardiotocographs (CTGs) monitor the fetal heart rate with an ultrasound transducer and maternal contractions with a toco (strain gauge) transducer. During labour, they give an indication of how the fetal heart rate (FHR) is responding to the stress caused by maternal contractions.\n\n## Problem\n\nAdverse outcomes are still being reported in the presence of CTG traces that appear normal.\n\nFor example, the display of double maternal heart rate (MHR x 2) can be falsely reassuring.\n\nCardiotocographs assist in the management of labour, but should not be relied upon in isolation to monitor the condition of the fetus.\n\nThe NICE clinical guideline 55 \u2018Intrapartum care\u2019 (chapter 1.12.2 Interpretation of FHR traces/cardiotocographs) classifies four FHR trace features: \u2018Baseline\u2019, \u2018Variability\u2019, \u2018Decelerations\u2019 and \u2018Accelerations\u2019.\n\nIt also gives values for \u2018Reassuring\u2019, \u2018Non-reassuring\u2019 and \u2018Abnormal\u2019.\n\nIt then uses these features to define \u2018Normal\u2019, \u2018Suspicious\u2019 and \u2018Pathological\u2019 FHR traces. See appendix for details.\n\nThese guidelines also recommend that the maternal pulse is palpated if a FHR abnormality is detected, in order to differentiate the two heart rates (sections 1.6.13 observations during first stage of labour and 1.7.6 second stage).\n\nThe problem is that adverse incident reports often state that the fetal heart rate was in the normal range and staff only suspect a FHR abnormality after the event. CTG users should be aware of the limitations and artefacts that can occur, which have important implications for interpretation.\n\nBelow are two examples of situations that have occurred in UK hospitals.\n\nExample 1: In two recently reported incidents the CTG trace showed the FHR was around 160 bpm. The maternal pulse had been noted earlier at around 80 bpm. In one case the baby was stillborn. In the other the baby required extensive resuscitation. It was later suspected that in both cases the trace was showing double maternal rate and was falsely reassuring.\n\nExplanation: The fetus can move out of the ultrasound field or in extreme cases the fetal heart can stop beating. The ultrasound may then pick up the maternal pulse from the aorta, iliac or uterine artery. The FHR displayed will then actually be the maternal heart rate, MHR. Sometimes the maternal artery movement is double counted so MHR x 2 is displayed. This can be within the same range as the expected FHR and can be more difficult to interpret. The resulting trace shows reactivity and variability due to MHR changes and muscle contractions and can be difficult to distinguish from FHR.\n\nExample 2: It has been observed that half the fetal heart rate (FHR \u00f7 2) can be displayed.\n\nExplanation: This can be due to difficulty in extracting the weak fetal heartbeat Doppler ultrasound signal from the noisy maternal environment.\n\n## Action\n\nLocal procedures for maintaining expertise should ensure that relevant clinical staff:  \n  \n  * do not rely solely on the CTG trace for fetal wellbeing and are aware of limitations and artefacts, such as double maternal heart rate being displayed  \n  * confirm fetal heart rate using independent means (Pinard or hand held Doppler) if there is any clinical uncertainly  \n  * read the manufacturer\u2019s instructions for use  \n  * are familiar with the [NICE clinical guideline for intrapartum careNICE clinical guideline for intrapartum care](http://guidance.nice.org.uk/CG55/NICEGuidance/pdf/English).  \n  \nCheck the presence of a fetal heartbeat by independent means (eg Pinard stethoscope, hand-held Doppler):\n\na) before starting CTG monitoring  \nb) after a period where the FHR trace is reassuring and then a change occurs  \nc) after a period where the FHR trace is non-reassuring and then appears to recover.\n\nConsider maternal ECG or pulse oximetry (SpO2) monitoring when using CTG monitors incorporating cross correlation software. This can alert the user when the FHR is the same value as the MHR.\n\nAlthough an alert may not be generated if the FHR trace is constantly showing MHR x2, the recording of maternal pulse makes it easier for the user to check whether the FHR display could be MHR x 2.\n\n## Distribution\n\nThis MDA has been distributed to:  \n  \n  * NHS trusts in England (chief executives)  \n  * HSC trusts in Northern Ireland (chief executives)  \n  * NHS boards in Scotland (chief executives)  \n  * NHS boards and trusts in Wales (chief executives)  \n  * Primary care trusts in England (chief executives)  \n  \nOnward distribution  \nPlease bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:\n\nTrusts to:  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * Anaesthetists  \n  * Clinical governance leads  \n  * Medical director  \n  * Midwifery staff  \n  * Nursing executive directors  \n  * Obstetricians  \n  * Risk managers  \n  \nCare Quality Commission (CQC) (England only) to:  \nThe MHRA considers this information to be important to:  \n  \n  * Hospitals in the independent sector  \n  * Private medical practitioners  \n  \nPrimary care trusts to:  \nCAS liaison officers for onward distribution to all relevant staff including:  \n  \n  * Community midwives  \n  \n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert, please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk)\n\n## Appendix\n\n[ASSET_TAG](#ASSET0) (71Kb) \n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2010/054 or file number 2010/002/005/291/001.\n\nTechnical aspects  \nGeoff Smith or Catriona Blake  \nMedicines & Healthcare products Regulatory Agency  \nMarket Towers  \n1 Nine Elms Lane London  \nSW8 5NQ\u00a0\n\nTel: 020 7084 3198/3219  \nFax: 020 7084 3209\n\nEmail: [geoff.smith@mhra.gsi.gov.uk](mailto:geoff.smith@mhra.gsi.gov.uk) or\u00a0[catriona.blake@mhra.gsi.gov.uk](mailto:catriona.blake@mhra.gsi.gov.uk)\n\nClinical aspects  \nJonathan Plumb  \nMedicines & Healthcare products Regulatory Agency  \nMarket Towers\u00a0  \n1 Nine Elms Lane London  \nSW8 5NQ\n\nTel: 020 7084 3128  \nFax: 020 7084 3111\n\nEmail: [jonathan.plumb@mhra.gsi.gov.uk](mailto:jonathan.plumb@mhra.gsi.gov.uk)\n\nHow to report adverse incidents  \nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm).  \nFurther information about CAS can be found on the [Central Alerting System website](https://www.cas.dh.gov.uk/Home.aspx) (external link).\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates  \nEstate Policy Directorate  \nStoney Road  \nDundonald  \nBelfast  \nBT16 1US\n\nTel: 02890 523 704  \nFax: 02890 523 900\n\nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n[Northern Ireland Adverse Incident Centre (NIAIC)](http://www.dhsspsni.gov.uk/index/hea/niaic.htm) (external link)\n\nSAN2002(23) was published in Northern Ireland under SN(NI)2002/28.\n\nHow to report adverse incidents in Northern Ireland  \nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link).  \nFurther information about SABS can be found on the [SABS website](http://sabs.dhsspsni.gov.uk/) (external link).\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\nIncident Reporting and Investigation Centre  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh  \nEH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Health Facilities Scotland - Incident Reporting and Investigation Centre](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link).\n\n## Wales\n\nEnquiries in Wales should be addressed to:\n\nDr Sara Hayes  \nSenior Medical Officer  \nMedical Device Alerts  \nWelsh Assembly Government  \nCathays Park  \nCardiff  \nCF10 3NQ\n\nTel: 029 2082 3922\u00a0\n\nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><font class=\"h4\">Fetal monitor/cardiotocograph (CTG).</font></p><p><font class=\"h4\">This replaces SN 2002(23) issued August 2002.</font></p><p>Cardiotocographs (CTGs) monitor the fetal heart rate with an ultrasound transducer and maternal contractions with a toco (strain gauge) transducer. During labour, they give an indication of how the fetal heart rate (FHR) is responding to the stress caused by maternal contractions.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p><font class=\"h4\">Adverse outcomes are still being reported in the presence of CTG traces that appear normal.</font></p><p><font class=\"h4\">For example, the display of double maternal heart rate (MHR x 2) can be falsely reassuring.</font></p><p>Cardiotocographs assist in the management of labour, but should not be relied upon in isolation to monitor the condition of the fetus.</p><p>The NICE clinical guideline 55 &#8216;Intrapartum care&#8217; (chapter 1.12.2 Interpretation of FHR traces/cardiotocographs) classifies four FHR trace features: &#8216;Baseline&#8217;, &#8216;Variability&#8217;, &#8216;Decelerations&#8217; and &#8216;Accelerations&#8217;.</p><p>It also gives values for &#8216;Reassuring&#8217;, &#8216;Non-reassuring&#8217; and &#8216;Abnormal&#8217;.</p><p>It then uses these features to define &#8216;Normal&#8217;, &#8216;Suspicious&#8217; and &#8216;Pathological&#8217; FHR traces. See appendix for details.</p><p>These guidelines also recommend that the maternal pulse is palpated if a FHR abnormality is detected, in order to differentiate the two heart rates (sections 1.6.13 observations during first stage of labour and 1.7.6 second stage).</p><p>The problem is that adverse incident reports often state that the fetal heart rate was in the normal range and staff only suspect a FHR abnormality after the event. CTG users should be aware of the limitations and artefacts that can occur, which have important implications for interpretation.</p><p>Below are two examples of situations that have occurred in UK hospitals.</p><p><span>Example 1:</span> In two recently reported incidents the CTG trace showed the FHR was around 160 bpm. The maternal pulse had been noted earlier at around 80 bpm. In one case the baby was stillborn. In the other the baby required extensive resuscitation. It was later suspected that in both cases the trace was showing double maternal rate and was falsely reassuring.</p><p><span>Explanation:</span> The fetus can move out of the ultrasound field or in extreme cases the fetal heart can stop beating. The ultrasound may then pick up the maternal pulse from the aorta, iliac or uterine artery. The FHR displayed will then actually be the maternal heart rate, MHR. <span>Sometimes the maternal artery movement is double counted so MHR x 2 is displayed. This can be within the same range as the expected FHR and can be more difficult to interpret.</span> The resulting trace shows reactivity and variability due to MHR changes and muscle contractions and can be difficult to distinguish from FHR.</p><p><span>Example 2:</span> It has been observed that half the fetal heart rate (FHR &#247; 2) can be displayed.</p><p><span>Explanation:</span> This can be due to difficulty in extracting the weak fetal heartbeat Doppler ultrasound signal from the noisy maternal environment.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<p><font class=\"h4\">Local procedures for maintaining expertise should ensure that relevant clinical staff:</font></p><ul>\r\n\t\t\t\t<li><font class=\"h4\">do not rely solely on the CTG trace for fetal wellbeing and are aware of limitations and artefacts, such as double maternal heart rate being displayed</font></li>\r\n\t\t\t\t<li><font class=\"h4\">confirm fetal heart rate using independent means (Pinard or hand held Doppler) if there is any clinical uncertainly</font></li>\r\n\t\t\t\t<li><font class=\"h4\">read the manufacturer&#8217;s instructions for use</font></li>\r\n\t\t\t\t<li><font class=\"h4\">are familiar with the</font>\r\n\t\t\t\t\t<a href=\"http://guidance.nice.org.uk/CG55/NICEGuidance/pdf/English\" target=\"_blank\">NICE clinical guideline for intrapartum care<font class=\"h4\">NICE clinical guideline for intrapartum care</font></a><font class=\"h4\">.</font></li></ul><p>Check the presence of a fetal heartbeat by independent means (eg Pinard stethoscope, hand-held Doppler):</p><p>a) before starting CTG monitoring<br>b) after a period where the FHR trace is reassuring and then a change occurs<br>c) after a period where the FHR trace is non-reassuring and then appears to recover.</p><p>Consider maternal ECG or pulse oximetry (SpO2) monitoring when using CTG monitors incorporating cross correlation software. This can alert the user when the FHR is the same value as the MHR.</p><p>Although an alert may not be generated if the FHR trace is constantly showing MHR x2, the recording of maternal pulse makes it easier for the user to check whether the FHR display could be MHR x 2.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been distributed to:</p><ul>\r\n\t\t\t\t<li>NHS trusts in England (chief executives)</li>\r\n\t\t\t\t<li>HSC trusts in Northern Ireland (chief executives)</li>\r\n\t\t\t\t<li>NHS boards in Scotland (chief executives)</li>\r\n\t\t\t\t<li>NHS boards and trusts in Wales (chief executives)</li>\r\n\t\t\t\t<li>Primary care trusts in England (chief executives)</li></ul><p><font class=\"h3\">Onward distribution</font><br>Please bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:</p><p><font class=\"h4\">Trusts to:</font><br>CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p><ul>\r\n\t\t\t\t<li>Anaesthetists</li>\r\n\t\t\t\t<li>Clinical governance leads</li>\r\n\t\t\t\t<li>Medical director</li>\r\n\t\t\t\t<li>Midwifery staff</li>\r\n\t\t\t\t<li>Nursing executive directors</li>\r\n\t\t\t\t<li>Obstetricians</li>\r\n\t\t\t\t<li>Risk managers</li></ul><p><font class=\"h4\">Care Quality Commission (CQC) (England only) to:<br></font> The MHRA considers this information to be important to:</p><ul>\r\n\t\t\t\t<li>Hospitals in the independent sector</li>\r\n\t\t\t\t<li>Private medical practitioners</li></ul><p><font class=\"h4\">Primary care trusts to:</font><br>CAS liaison officers for onward distribution to all relevant staff including:</p><ul>\r\n\t\t\t\t<li>Community midwives</li></ul>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\tIf you have any comments or feedback on this Medical Device Alert, please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\">dts@mhra.gsi.gov.uk</a>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\r\n<h2 class=\"sw\">Appendix</h2><div class=\"content_section\" id=\"Appendix\">\r\n\t\t\t\t\t\t\t\t<a href=\"#ASSET0\">ASSET_TAG</a> (71Kb)\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2010/054</span> or file number <span>2010/002/005/291/001</span>.</p><p><font class=\"h4\">Technical aspects<br></font>Geoff Smith or Catriona Blake<br>Medicines &amp; Healthcare products Regulatory Agency<br>Market Towers<br>1 Nine Elms Lane London<br>SW8 5NQ&#160;</p><p>Tel: 020 7084 3198/3219<br>Fax: 020 7084 3209</p><p>Email: <a href=\"mailto:geoff.smith@mhra.gsi.gov.uk\">geoff.smith@mhra.gsi.gov.uk</a> or&#160;<a href=\"mailto:catriona.blake@mhra.gsi.gov.uk\">catriona.blake@mhra.gsi.gov.uk</a></p><p><font class=\"h4\">Clinical aspects</font><br>Jonathan Plumb<br>Medicines &amp; Healthcare products Regulatory Agency<br>Market Towers&#160;<br>1 Nine Elms Lane London<br>SW8 5NQ</p><p>Tel: 020 7084 3128<br>Fax: 020 7084 3111</p><p>Email: <a href=\"mailto:jonathan.plumb@mhra.gsi.gov.uk\">jonathan.plumb@mhra.gsi.gov.uk</a></p><p><font class=\"h3\">How to report adverse incidents</font><br>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\">Reporting adverse incidents involving medical devices</a>.<br>Further information about CAS can be found on the <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\">Central Alerting System website</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p><p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p><p>Northern Ireland Adverse Incident Centre<br>Health Estates<br>Estate Policy Directorate<br>Stoney Road<br>Dundonald<br>Belfast<br>BT16 1US</p><p>Tel: 02890 523 704<br>Fax: 02890 523 900</p><p>Email: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\">NIAIC@dhsspsni.gov.uk</a></p><p><a href=\"http://www.dhsspsni.gov.uk/index/hea/niaic.htm\" target=\"_blank\">Northern Ireland Adverse Incident Centre (NIAIC)</a> (external link)</p><p>SAN2002(23) was published in Northern Ireland under SN(NI)2002/28.</p><p><font class=\"h3\">How to report adverse incidents in Northern Ireland</font><br>Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" target=\"_blank\">NIAIC website</a> (external link).<br>Further information about SABS can be found on the <a href=\"http://sabs.dhsspsni.gov.uk/\" target=\"_blank\">SABS website</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p><p>Incident Reporting and Investigation Centre<br>Health Facilities Scotland<br>NHS National Services Scotland<br>Gyle Square<br>1 South Gyle Crescent<br>Edinburgh<br>EH12 9EB</p><p>Tel: 0131 275 7575<br>Fax: 0131 314 0722</p><p>Email: <a href=\"mailto:nss.iric@nhs.net\">nss.iric@nhs.net</a></p><p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\">Health Facilities Scotland - Incident Reporting and Investigation Centre</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:</p><p>Dr Sara Hayes<br>Senior Medical Officer<br>Medical Device Alerts<br>Welsh Assembly Government<br>Cathays Park<br>Cardiff<br>CF10 3NQ</p><p>Tel: 029 2082 3922&#160;</p><p>Email: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: Fetal monitor/cardiotocograph (CTG) (MDA/2010/054)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": []
}